Kristopher A. Lofgren

594 total citations
20 papers, 451 citations indexed

About

Kristopher A. Lofgren is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Kristopher A. Lofgren has authored 20 papers receiving a total of 451 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 11 papers in Molecular Biology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Kristopher A. Lofgren's work include HER2/EGFR in Cancer Research (6 papers), Lung Cancer Treatments and Mutations (4 papers) and Cancer Diagnosis and Treatment (3 papers). Kristopher A. Lofgren is often cited by papers focused on HER2/EGFR in Cancer Research (6 papers), Lung Cancer Treatments and Mutations (4 papers) and Cancer Diagnosis and Treatment (3 papers). Kristopher A. Lofgren collaborates with scholars based in United States, Switzerland and Czechia. Kristopher A. Lofgren's co-authors include Carol A. Lange, Andrea R. Daniel, Julie H. Ostrander, Celina G. Kleer, Paraic A. Kenny, Amanda Jiang, Mathumai Kanapathipillai, Elaine P.S. Gee, Akiko Mammoto and Tadanori Mammoto and has published in prestigious journals such as Nature Communications, Cancer Research and Breast Cancer Research and Treatment.

In The Last Decade

Kristopher A. Lofgren

18 papers receiving 450 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kristopher A. Lofgren United States 9 278 198 88 77 52 20 451
Anthony G. Clementz United States 8 321 1.2× 220 1.1× 84 1.0× 68 0.9× 38 0.7× 9 497
Verónica Calvo United States 9 265 1.0× 218 1.1× 167 1.9× 51 0.7× 98 1.9× 13 513
Yong‐Jian Deng China 12 237 0.9× 153 0.8× 108 1.2× 44 0.6× 53 1.0× 21 424
R. Habets Netherlands 8 357 1.3× 178 0.9× 161 1.8× 56 0.7× 32 0.6× 8 535
Mariam Gachechiladze Czechia 11 255 0.9× 207 1.0× 81 0.9× 81 1.1× 67 1.3× 30 486
M. Ángeles Villaronga Spain 17 420 1.5× 139 0.7× 162 1.8× 74 1.0× 40 0.8× 28 577
Yvonne E. Smith Ireland 9 228 0.8× 185 0.9× 130 1.5× 140 1.8× 32 0.6× 10 430
Hemanth J. Varghese Canada 7 208 0.7× 276 1.4× 162 1.8× 60 0.8× 56 1.1× 8 458
Darío García‐Carracedo Spain 11 269 1.0× 221 1.1× 115 1.3× 63 0.8× 30 0.6× 20 480
Roger S. Jackson United States 11 392 1.4× 189 1.0× 118 1.3× 147 1.9× 47 0.9× 14 620

Countries citing papers authored by Kristopher A. Lofgren

Since Specialization
Citations

This map shows the geographic impact of Kristopher A. Lofgren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kristopher A. Lofgren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kristopher A. Lofgren more than expected).

Fields of papers citing papers by Kristopher A. Lofgren

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kristopher A. Lofgren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kristopher A. Lofgren. The network helps show where Kristopher A. Lofgren may publish in the future.

Co-authorship network of co-authors of Kristopher A. Lofgren

This figure shows the co-authorship network connecting the top 25 collaborators of Kristopher A. Lofgren. A scholar is included among the top collaborators of Kristopher A. Lofgren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kristopher A. Lofgren. Kristopher A. Lofgren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lofgren, Kristopher A., et al.. (2024). Gemcitabine combination therapies induce apoptosis in uterine carcinosarcoma patient-derived organoids. Frontiers in Oncology. 14. 1368592–1368592. 2 indexed citations
2.
Lofgren, Kristopher A. & Paraic A. Kenny. (2023). Grb7 knockout mice develop normally but litters born to knockout females fail to thrive. Developmental Dynamics. 253(7). 677–689. 2 indexed citations
3.
Lofgren, Kristopher A., et al.. (2022). Pan-cancer distribution of cleaved cell-surface amphiregulin, the target of the GMF-1A3 antibody drug conjugate. PubMed. 5(3). 226–231. 3 indexed citations
4.
Lofgren, Kristopher A., et al.. (2021). Anti-tumor efficacy of an MMAE-conjugated antibody targeting cell surface TACE/ADAM17-cleaved Amphiregulin in breast cancer. PubMed. 4(4). 252–261. 9 indexed citations
5.
Parsons, Benjamin M., Craig S. Richmond, Grzegorz T. Gurda, et al.. (2020). Acquisition of Cabozantinib-Sensitive MET D1228N Mutation During Progression on Crizotinib in MET-Amplified Triple-Negative Breast Cancer. Clinical Breast Cancer. 20(4). e433–e438. 11 indexed citations
6.
Lofgren, Kristopher A., et al.. (2019). Amphiregulin deletion strongly attenuates the development of estrogen receptor-positive tumors in p53 mutant mice. Breast Cancer Research and Treatment. 179(3). 653–660. 4 indexed citations
7.
Parsons, Benjamin M., Sreeja Sreekumar, Craig S. Richmond, et al.. (2019). Abstract 1317: Exceptional responses to crizotinib in breast cancer patients with somatic MET and ROS1 alterations. Cancer Research. 79(13_Supplement). 1317–1317. 2 indexed citations
8.
Parsons, Benjamin M., Sreeja Sreekumar, Craig S. Richmond, et al.. (2019). Abstract 1317: Exceptional responses to crizotinib in breast cancer patients with somatic MET and ROS1 alterations. 1317–1317.
9.
Lofgren, Kristopher A., et al.. (2018). Mutant GATA3 Actively Promotes the Growth of Normal and Malignant Mammary Cells. Anticancer Research. 38(8). 4435–4441. 24 indexed citations
10.
11.
Parsons, Benjamin M., et al.. (2017). Exceptional Response to Crizotinib in an MET-Amplified Triple-Negative Breast Tumor. JCO Precision Oncology. 1(1). 1–6. 5 indexed citations
12.
Lofgren, Kristopher A., et al.. (2017). Genomic analysis of melanoma evolution following a 30‐year disease‐free interval. Journal of Cutaneous Pathology. 44(9). 805–808. 5 indexed citations
13.
Lofgren, Kristopher A. & Paraic A. Kenny. (2016). An instructive ductal microenvironment is key for efficient in vivo modeling of estrogen receptor positive breast cancer. Translational Cancer Research. 5(2). 1 indexed citations
14.
Lofgren, Kristopher A. & Paraic A. Kenny. (2016). An instructive ductal microenvironment is key for efficient in vivo modeling of estrogen receptor positive breast cancer. Translational Cancer Research. 5(S2). S360–S362. 1 indexed citations
15.
Peterson, Esther A., Edmund C. Jenkins, Kristopher A. Lofgren, et al.. (2015). Amphiregulin Is a Critical Downstream Effector of Estrogen Signaling in ERα-Positive Breast Cancer. Cancer Research. 75(22). 4830–4838. 41 indexed citations
16.
Peacock, Danielle L., Andrea R. Daniel, Kristopher A. Lofgren, et al.. (2013). Breast Tumor Kinase (Brk/PTK6) Is a Mediator of Hypoxia-Associated Breast Cancer Progression. Cancer Research. 73(18). 5810–5820. 48 indexed citations
17.
Mammoto, Akiko, Tadanori Mammoto, Mathumai Kanapathipillai, et al.. (2013). Control of lung vascular permeability and endotoxin-induced pulmonary oedema by changes in extracellular matrix mechanics. Nature Communications. 4(1). 1759–1759. 110 indexed citations
18.
Lofgren, Kristopher A., Julie H. Ostrander, Daniel Housa, et al.. (2011). Mammary gland specific expression of Brk/PTK6 promotes delayed involution and tumor formation associated with activation of p38 MAPK. Breast Cancer Research. 13(5). R89–R89. 28 indexed citations
19.
Lofgren, Kristopher A., et al.. (2011). Mechanisms of HGF/Met Signaling to Brk and Sam68 in Breast Cancer Progression. Hormones and Cancer. 3(1-2). 14–25. 42 indexed citations
20.
Ostrander, Julie H., Andrea R. Daniel, Kristopher A. Lofgren, Celina G. Kleer, & Carol A. Lange. (2007). Breast Tumor Kinase (Protein Tyrosine Kinase 6) Regulates Heregulin-Induced Activation of ERK5 and p38 MAP Kinases in Breast Cancer Cells. Cancer Research. 67(9). 4199–4209. 113 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anthony G. Clementz Breakdown of academic impact, for papers by Verónica Calvo Breakdown of academic impact, for papers by Yong‐Jian Deng Breakdown of academic impact, for papers by R. Habets Breakdown of academic impact, for papers by Mariam Gachechiladze Breakdown of academic impact, for papers by M. Ángeles Villaronga Breakdown of academic impact, for papers by Yvonne E. Smith Breakdown of academic impact, for papers by Hemanth J. Varghese Breakdown of academic impact, for papers by Darío García‐Carracedo Breakdown of academic impact, for papers by Roger S. Jackson
Rankless by CCL
2026